Compare, Analyse PLETHICO PHARMA with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PLETHICO PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
ADCOCK INGRAM
Jun-14
PLETHICO PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs395352-   
Low Rs31254-   
Sales per share (Unadj.) Rs604.4104.6-  
Earnings per share (Unadj.) Rs32.5-26.4-  
Cash flow per share (Unadj.) Rs51.3-21.8-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs473.682.1-  
Shares outstanding (eoy) m34.08168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.42.9 12.2%   
Avg P/E ratio x6.6-11.5 -57.1%  
P/CF ratio (eoy) x4.2-13.9 -30.0%  
Price / Book Value ratio x0.53.7 12.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m7,26251,080 14.2%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m1,5963,206 49.8%   
Avg. sales/employee Rs ThNM4,112.3-  
Avg. wages/employee Rs ThNM746.8-  
Avg. net profit/employee Rs ThNM-1,036.2-  
INCOME DATA
Net Sales Rs m20,59817,654 116.7%  
Other income Rs m386124 312.5%   
Total revenues Rs m20,98417,778 118.0%   
Gross profit Rs m2,818-3,059 -92.1%  
Depreciation Rs m642762 84.3%   
Interest Rs m1,593478 333.2%   
Profit before tax Rs m969-4,176 -23.2%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-138261 -53.0%   
Profit after tax Rs m1,107-4,448 -24.9%  
Gross profit margin %13.7-17.3 -78.9%  
Effective tax rate %-14.3-6.2 228.7%   
Net profit margin %5.4-25.2 -21.3%  
BALANCE SHEET DATA
Current assets Rs m18,87712,930 146.0%   
Current liabilities Rs m11,8967,275 163.5%   
Net working cap to sales %33.932.0 105.8%  
Current ratio x1.61.8 89.3%  
Inventory Days Days36111 32.4%  
Debtors Days Days198124 159.6%  
Net fixed assets Rs m9,8617,537 130.8%   
Share capital Rs m34182 415.7%   
"Free" reserves Rs m12,3310-   
Net worth Rs m16,13913,856 116.5%   
Long term debt Rs m4,7064,869 96.6%   
Total assets Rs m33,14626,176 126.6%  
Interest coverage x1.6-7.7 -20.8%   
Debt to equity ratio x0.30.4 83.0%  
Sales to assets ratio x0.60.7 92.1%   
Return on assets %8.1-15.2 -53.7%  
Return on equity %6.9-32.1 -21.4%  
Return on capital %12.3-19.8 -62.0%  
Exports to sales %21.40-   
Imports to sales %15.20-   
Net fx Rs m1,2190-   
CASH FLOW
From Operations Rs m2,4371,507 161.7%  
From Investments Rs m-6,265-463 1,354.0%  
From Financial Activity Rs m2,4904,419 56.3%  
Net Cashflow Rs m-1,3375,464 -24.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.85 Rs / ZAR

Compare PLETHICO PHARMA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare PLETHICO PHARMA With: WOCKHARDT  DR. REDDYS LAB  LUPIN  SUVEN LIFESCIENCES  ALKEM LABORATORIES  



Today's Market

Sensex Ends 95 Points Higher; Automobile and IT Stocks Witness Buying(Closing)

Indian share markets traded rangebound throughout the day and ended marginally higher. Sectoral indices ended on a mixed note with stocks in the automobile sector.

Related Views On News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market (The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA - LUPIN COMPARISON

COMPARE PLETHICO PHARMA WITH

MARKET STATS